Innate Pharma S.A. (EPA: IPH)
France
· Delayed Price · Currency is EUR
1.584
+0.114 (7.76%)
Nov 20, 2024, 5:35 PM CET
Innate Pharma Employees
Innate Pharma had 179 employees as of December 31, 2023. The number of employees decreased by 32 or -15.17% compared to the previous year.
Employees
179
Change (1Y)
-32
Growth (1Y)
-15.17%
Revenue / Employee
€201,119
Profits / Employee
€202,690
Market Cap
128.23M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
EssilorLuxottica Société anonyme | 151,292 |
Ipsen S.A. | 5,325 |
Eurofins Scientific SE | 61,798 |
ABIVAX Société Anonyme | 61 |
MedinCell S.A. | 134 |
Eurobio Scientific Société anonyme | 300 |
Inventiva S.A. | 123 |
Nanobiotix S.A. | 102 |
Innate Pharma News
- 13 days ago - Innate Pharma Highlights Data From Its Innovative Oncology Portfolio Selected for the SITC Annual Meeting 2024 - Business Wire
- 14 days ago - Innate Pharma Announces Conference Call and Webcast for Third Quarter 2024 Results and Business Updates - Business Wire
- 23 days ago - Innate Pharma Announces Its Participation in Upcoming Investor Conferences - Business Wire
- 5 weeks ago - Innate Pharma appoints Jonathan Dickinson as new CEO and Chairman of executive board - Seeking Alpha
- 5 weeks ago - Innate Pharma Appoints Jonathan Dickinson as New Chief Executive Officer and Chairman of the Executive Board - Business Wire
- 7 weeks ago - Innate Pharma to Host KOL Scientific Symposium on Immunotherapy in New York on October 3, 2024 - Business Wire
- 2 months ago - Innate gets FDA clearance for Phase 1 study for IPH4502 ADC candidate - Seeking Alpha
- 2 months ago - Innate Pharma Announces FDA Clearance of the IND for IPH4502, a Nectin-4 ADC to Be Developed in Solid Tumors - Business Wire